Page 20 - Scientific Program News Today

/PRNewswire/ -- The International Society of Heart and Lung Transplantation has announced the results of the member election for the 2022 Board of Directors....

Martin Blume, who served 12 years as deputy director at Brookhaven National Laboratory, died on Wednesday, October 6, 2021. He was 89.

Preclinical Data Demonstrates that BEAM-102 Makassar Base Editing Converts Sickle Hemoglobin to Functional Hemoglobin for Potential Treatment of Sickle...

We are pleased to announce that the “36th Şişecam Glass Symposium” with the theme ”Glass is Future” will be held online on November 12, 2021.

Cypress, CA (PRWEB) October 15, 2021 -- Following last year’s all-virtual event, this year’s Global Congress, titled Celebrating 50 Years of Gynecologic

Two independent studies have illuminated unexpected substructures in the fundamental components of all matter. Preliminary results using a novel

HUTCHMED and AstraZeneca Initiate Phase II Trial of ORPATHYS® in Patients with MET Amplified Gastric Cancer — Follows multiple Phase II studies of ORPATHYS® in Asia including VIKTORY, which reported an 50% objective response rate (ORR) in gastric cancer patients whose tumors harbor MET amplification — July 27, 2021 20:00 ET | Source: HUTCHMED (China) Limited HUTCHMED (China) Limited Kowloon, HONG KONG HONG KONG, SHANGHAI, FLORHAM PARK, N.J.,...

Tislelizumab demonstrated a 30% reduction in the risk of death and extended median overall survival by 2.3 months compared to chemotherapy in advanced or metastatic esophageal squamous cell carcinoma after

/PRNewswire/ -- Novartis today announced the first published mature overall survival (OS) and updated overall response rate (ORR) data following treatment with...

Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis investigational checkpoint inhibitor tislelizumab met primary endpoint of overall survival in pivotal Phase III trial of esophageal cancer after systemic therapy